[HTML][HTML] Alpha synuclein post translational modifications: potential targets for Parkinson's disease therapy?
V Brembati, G Faustini, F Longhena… - Frontiers in molecular …, 2023 - frontiersin.org
Parkinson's disease (PD) is the most common neurodegenerative disorder with motor
symptoms. The neuropathological alterations characterizing the brain of patients with PD …
symptoms. The neuropathological alterations characterizing the brain of patients with PD …
Alpha synuclein post translational modifications: potential targets for Parkinson's disease therapy?
V Brembati, G Faustini… - Frontiers in …, 2023 - pubmed.ncbi.nlm.nih.gov
Parkinson's disease (PD) is the most common neurodegenerative disorder with motor
symptoms. The neuropathological alterations characterizing the brain of patients with PD …
symptoms. The neuropathological alterations characterizing the brain of patients with PD …
Alpha synuclein post translational modifications: potential targets for Parkinson's disease therapy?
V Brembati, G Faustini, F Longhena… - Frontiers in Molecular …, 2023 - europepmc.org
Parkinson's disease (PD) is the most common neurodegenerative disorder with motor
symptoms. The neuropathological alterations characterizing the brain of patients with PD …
symptoms. The neuropathological alterations characterizing the brain of patients with PD …
[PDF][PDF] Alpha synuclein post translational modifications: potential targets fo r Parkinson's disease therapy?
V Brembati, G Faustini, F Longhena, A Bellucci - 2023 - core.ac.uk
Parkinson's disease (PD) is the second most common movement disorder, affecting 2% of
the world population over 65 years of age (Baker and Graham, 2004). Motor symptoms …
the world population over 65 years of age (Baker and Graham, 2004). Motor symptoms …
Alpha synuclein post translational modifications: potential targets for Parkinson's disease therapy?
V Brembati, G Faustini, F Longhena… - Frontiers in Molecular …, 2023 - search.ebscohost.com
Parkinson's disease (PD) is the most common neurodegenerative disorder with motor
symptoms. The neuropathological alterations characterizing the brain of patients with PD …
symptoms. The neuropathological alterations characterizing the brain of patients with PD …
[HTML][HTML] Alpha synuclein post translational modifications: potential targets for Parkinson's disease therapy?
V Brembati, G Faustini, F Longhena… - Frontiers in Molecular …, 2023 - ncbi.nlm.nih.gov
Parkinson's disease (PD) is the most common neurodegenerative disorder with motor
symptoms. The neuropathological alterations characterizing the brain of patients with PD …
symptoms. The neuropathological alterations characterizing the brain of patients with PD …
Alpha synuclein post translational modifications: potential targets for Parkinson's disease therapy?
V Brembati, G Faustini, F Longhena… - Frontiers in Molecular …, 2023 - search.proquest.com
Parkinson's disease (PD) is the most common neurodegenerative disorder with motor
symptoms. The neuropathological alterations characterizing the brain of patients with PD …
symptoms. The neuropathological alterations characterizing the brain of patients with PD …
Alpha synuclein post translational modifications: potential targets for Parkinson's disease therapy?
V Brembati, G Faustini, F Longhena… - FRONTIERS IN …, 2023 - iris.unibs.it
Parkinson's disease (PD) is the most common neurodegenerative disorder with motor
symptoms. The neuropathological alterations characterizing the brain of patients with PD …
symptoms. The neuropathological alterations characterizing the brain of patients with PD …
[PDF][PDF] Alpha synuclein post translational modifications: potential targets fo r Parkinson's disease therapy?
V Brembati, G Faustini, F Longhena, A Bellucci - 2023 - iris.unibs.it
Parkinson's disease (PD) is the second most common movement disorder, affecting 2% of
the world population over 65 years of age (Baker and Graham, 2004). Motor symptoms …
the world population over 65 years of age (Baker and Graham, 2004). Motor symptoms …